B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins

Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management

(2013) Jan Peveling-Oberhag et al.   JOURNAL OF HEPATOLOGY

Structural and genetic basis for development of broadly neutralizing influenza antibodies

(2012) Daniel Lingwood et al.   NATURE

A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity

(2012) P. P. Ng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals

(2012) Miroslaw K. Gorny et al.   VIROLOGY

Molecular Signatures of Hepatitis C Virus (HCV)-Induced Type II Mixed Cryoglobulinemia (MCII)

(2012) Giuseppe Sautto et al.   Viruses-Basel

Identification and Targeting of an Interaction between a Tyrosine Motif within Hepatitis C Virus Core Protein and AP2M1 Essential for Viral Assembly

(2012) Gregory Neveu et al.   PLoS Pathogens

Exploitation of Lipid Components by Viral and Host Proteins for Hepatitis C Virus Infection

(2012) Kohji Moriishi et al.   Frontiers in Microbiology

Hepatitis C Patient-Derived Glycoproteins Exhibit Marked Differences in Susceptibility to Serum Neutralizing Antibodies: Genetic Subtype Defines Antigenic but Not Neutralization Serotype

(2011) A. W. Tarr et al.   JOURNAL OF VIROLOGY

Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5

(2011) N. Ohshima et al.   JOURNAL OF VIROLOGY

Blocking Hepatitis C Virus Infection with Recombinant Form of Envelope Protein 2 Ectodomain

(2009) J. Whidby et al.   JOURNAL OF VIROLOGY